Clinical studies have demonstrated that use of tenofovir disoproxil fumarate with or without
emtricitabine as antiretroviral pre-exposure prophylaxis (PrEP) can decrease the risk of …

Background Mathematical transmission models are increasingly used to guide public health
interventions for infectious diseases, particularly in the context of emerging pathogens; …

Background: In 2014, approximately 40,000 persons in the United States received a
diagnosis of human immunodeficiency virus (HIV) infection. Preexposure prophylaxis (PrEP) …

Background HIV transmission in men who have sex with men (MSM) in the UK has shown
no sign of decreasing in the past decade. Additional prevention measures are needed. We …

Background: Pre-exposure prophylaxis (PrEP) for prevention of HIV infection has
demonstrated efficacy in randomized controlled trials and in demonstration projects. For …

Background: The US President's Emergency Plan for AIDS Relief's (PEPFAR) first
implemented pre-exposure prophylaxis (PrEP) for HIV prevention through the Determined …

TDR is on the rise after the recent scale-up of ART in Africa. To prevent the development and
spread of drug resistance and sustain the effectiveness of ART programmes, there is a need …

The Center for the AIDS Programme of Research in South Africa (CAPRISA) 004 and Pre-
exposure Prophylaxis Initiative (iPrEx) studies demonstrated that topical or oral …

Thanks to the Affordable Care Act, thousands of people living with HIV who have received
Ryan White HIV/AIDS Program–funded care are now eligible for Medicaid or subsidized …

Background: The total population health benefits and costs of HIV preexposure prophylaxis
(PrEP) for people who inject drugs (PWID) in the United States are unclear. Objective: To …